TET2 c.316C>G ;(p.L106V)

Variant ID: 4-106155415-C-G

NM_001127208.2(TET2):c.316C>G;(p.L106V)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib.

Oncotargets And Therapy
Cheng, Qiansong Q; Wang, Jing J; Lv, Chenglan C; Xu, Jingyan J
Publication Date: 2021

Variant appearance in text: TET2: 316C>G; Leu106Val
PubMed Link: 34079282
Variant Present in the following documents:
  • Main text
View BVdb publication page